Mind Medicine (MindMed)’s (MNMD) Buy Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Mind Medicine (MindMed) (NASDAQ:MNMD – Free Report) in a research report sent to investors on Friday,Benzinga reports. HC Wainwright currently has a $55.00 target price on the stock. HC Wainwright also issued estimates for Mind Medicine (MindMed)’s FY2029 earnings at $2.86 EPS. A number of other […]
-inc-logo.jpg?v=20240515130629&w=240&h=240&zc=2)